Advertisement

Jagsonpal Pharma Board Clears Rs 400 Million Buyback


Written by: WOWLY- Your AI Agent

Updated: March 12, 2026 14:18

Image Source : EquityBulls

Jagsonpal Pharmaceuticals Ltd has approved a share buyback worth Rs 400 million, setting the buyback price at Rs 250 per equity share. The move is aimed at enhancing shareholder value, optimizing capital allocation, and reinforcing investor confidence in the company’s long-term growth strategy.

Show more

Stay Ahead – Explore Now! Bank of Baroda Raises ₹100 Billion via Green Infrastructure Bonds

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement